
About Optigenex
Optigenex is a publicly listed company based in Melissa (United States) founded in 2002 by Edward P. Optigenex is focused on healthy aging technology development. It operates on a Licensing Model model. Optigenex offers products and services including ac-11®. Its focus areas include Biotechnology and Natural Supplements. Its legal entity is Optigenex Inc. Its competitors include Biote, Timeline and Ponce De Leon Health.
Company details
Optigenex is engaged in developing patented, all-natural technologies for healthy aging, targeting the dietary supplement and skincare industries. Solutions are based on ac-11, a hot water extract of Uncaria tomentosa from the Amazon rainforest, aimed at supporting DNA repair. Research and sustainability are emphasized, with operations compliant with USDA, ISO 9002, FDA regulations, and GMP standards. Licensing opportunities are offered to manufacturers, distributors, and retailers worldwide.
- Headquarters Melissa, United States
- Founders Edward P
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website optigenex.com
- Social LinkedIn
- Legal Name Optigenex Inc
- Latest Funding Round$630K (USD), Post-IPO
Nov 2017
Products & Services of Optigenex
Optigenex offers a comprehensive portfolio of products and services, including ac-11®.
Extract of Uncaria tomentosa supporting DNA repair naturally.
Funding Insights of Optigenex
- Total Rounds 1
- Last Round Post-IPO — $630,000
- First Round $630,000
(Nov 2017)
All 1 funding rounds of Optigenex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $630,000 | Post-IPO | – | – | – |
People of Optigenex
1 people are tracked at Optigenex (1 in leadership).
| Name | Role | Group |
|---|---|---|
Edward P | Founder | Leadership |
Complete people profiles for Optigenex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Optigenex
Optigenex is a publicly listed company on the OTC with ticker symbol OPGX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Apr 2005
- Listed onOTCMKTS: OPGX
- Listed entityOPTIGENEX INC
- Exchange sectorHealth technology
- ISINUS6838863032
- Share price$0.00 · 2026-05-11
- Volume (last session)628
- Analyst consensusNo rating
Timeline of Optigenex
3 dated milestones of Optigenex across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Optigenex is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $630K.
Competitors of Optigenex
Optigenex has 3 listed competitors in our database. They include Biote, Timeline and Ponce De Leon Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biote.com | 2011 | Irving, United States | Hormone replacement and pellet therapy services are offered. | |||
| timeline.com | 2007 | San Francisco, United States | Clinically-tested Urolithin A supplements and skincare are developed. | |||
| pdlhealth.com | 2014 | Fernandina Beach, United States | Anti-aging nutraceutical supplements are developed and tested. |
Detailed competitors of Optigenex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Optigenex
The website of Optigenex (optigenex.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 1.4% vs previous month
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Optigenex (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Optigenex
Optigenex was founded in 2002 and raised its 1st funding round 15 years after it was founded.
Optigenex is headquartered in Melissa, United States. It is registered at Melissa, Texas, United States.
Optigenex is engaged in developing patented, all-natural technologies for healthy aging, targeting the dietary supplement and skincare industries. Solutions are based on ac-11, a hot water extract of Uncaria tomentosa from the Amazon rainforest, aimed at supporting DNA repair. Research and sustainability are emphasized, with operations compliant with USDA, ISO 9002, FDA regulations, and GMP standards. Licensing opportunities are offered to manufacturers, distributors, and retailers worldwide.
Optigenex's top competitors include Biote, Timeline and Ponce De Leon Health.
Optigenex offers ac-11®.
Yes, Optigenex is publicly traded on OTC under the ticker symbol OPGX.
Optigenex operates through Optigenex Inc..